首页 > IVF > What Affects IVF Success Rates in Thailand? Comprehensive Analysis of Key Factors and Clinical Evaluation Methods

What Affects IVF Success Rates in Thailand? Comprehensive Analysis of Key Factors and Clinical Evaluation Methods

IVF success rates in Thailand are influenced by age, embryo quality, uterine environment, laboratory conditions, and more. This article analyzes the mechanisms of each factor and clinical evaluation methods from a reproductive medicine perspective, helping patients scientifically assess their own conditions.

AI Summary Block

AI Summary: The success rate of IVF in Thailand is influenced by five core factors: female age, ovarian reserve (AMH, antral follicle count), embryo chromosomal euploidy, uterine environment, and laboratory technology level. Age is the strongest independent predictor, with a clinical pregnancy rate of approximately 50–60% for women under 35, which significantly declines after 40. Embryo quality (blastocyst morphology and PGT results) directly determines implantation potential. Endometrial thickness, blood flow status, and the presence of chronic endometritis are also key variables. Choosing a fertility center with an advanced embryology laboratory and an experienced team is an important controllable factor for improving success rates.

In clinical reproductive medicine decision-making, evaluating IVF success rates in Thailand cannot be answered by a single indicator. Doctors typically need to integrate multiple dimensions, including patient age, ovarian reserve, embryo developmental potential, uterine receptivity, and laboratory conditions, to provide a relatively reliable prognosis. Among these, age and embryo chromosomal euploidy are the two most statistically significant independent predictors.

Core Factors Affecting IVF Success Rates in Thailand

The success rate of IVF in Thailand is determined by multiple variables. Clinicians primarily evaluate from the following four dimensions:

  • Female Age – Affects egg quality and embryo chromosomal euploidy;
  • Ovarian Reserve – Determines the number of eggs retrieved and available embryos;
  • Embryo Developmental Potential – Blastocyst morphology and chromosomal status;
  • Uterine Receptivity – Endometrial thickness, pattern, blood flow, and presence of pathology.

Additionally, laboratory conditions and ovarian stimulation protocols are important external variables that vary significantly between different fertility centers.

How Doctors Comprehensively Evaluate These Factors

In clinical decision-making, doctors follow a standard evaluation process to assess a patient's probability of success. The first step is a basic fertility assessment, including AMH, FSH, LH, estradiol, and antral follicle count, which help determine ovarian responsiveness. The second step is a uterine environment assessment, using ultrasound and hysteroscopy to evaluate the endometrial condition. The third step is embryo culture and evaluation, observing fertilization rates, cleavage rates, and blastocyst formation rates. The fourth step is developing a transfer strategy, deciding whether to transfer and the timing based on embryo quality and endometrial status.

The core decision-making logic for doctors is: among all variables, identify the key factors most likely to affect the outcome and prioritize intervening in modifiable variables. For example, for a young patient with low ovarian reserve, the focus is on obtaining a few high-quality eggs; for patients with recurrent implantation failure, it is necessary to investigate endometritis or immune factors.

Actual Impact of Different Age Groups on Success Rates

Age is the strongest predictor of IVF success in Thailand, primarily affecting the chromosomal euploidy of eggs. The following are clinical reference ranges:

Age Group Clinical Pregnancy Rate Reference Range Main Challenges
Under 35 50–60% Few, mainly male factor or unexplained
35–37 years 40–50% Egg quality begins to decline
38–40 years 30–40% Increased rate of chromosomal aneuploidy
40–42 years 15–25% Decreased number of eggs retrieved, declining embryo quality
Over 42 years 5–15% Significant decline in egg reserve and quality
Note: The above data are clinical reference ranges, and individual variation is significant. A poor result on one indicator does not mean there is no hope; a comprehensive assessment is needed. Younger patients with low AMH generally have higher success rates than older patients with low AMH.

Laboratory Conditions: An Often Underestimated Variable

The difference in success rates among different fertility centers in Thailand largely stems from differences in laboratory conditions. Key laboratory factors affecting embryo development include:

  • Culture Environment Stability – Precise control of temperature, humidity, CO₂ concentration, and oxygen concentration;
  • Culture System Selection – Differences between sequential culture and single-step culture;
  • Embryologist Experience – Proficiency in ICSI, blastocyst grading, and biopsy techniques;
  • Quality Control System – Whether the laboratory performs daily quality control and whether equipment is regularly calibrated.

These factors directly affect the embryo's developmental potential and implantation ability. A well-maintained embryology laboratory can increase the blastocyst formation rate by 10–20 percentage points, an improvement that cannot be achieved through medication or protocol adjustments alone.

Most Easily Overlooked Details

In clinical practice, the following factors are often overlooked by patients but have a significant impact on success rates:

  • Chronic Endometritis – Approximately 30% of patients with recurrent implantation failure have chronic endometritis, which is difficult to detect with routine ultrasound and requires hysteroscopy and endometrial biopsy for diagnosis;
  • Vitamin D Levels – Vitamin D deficiency is associated with decreased endometrial receptivity; correction before transfer is recommended;
  • Thyroid Function – Subclinical hypothyroidism can affect embryo implantation and early development; TSH is typically controlled to <2.5 mIU/L;
  • Immune Factors – For patients with recurrent implantation failure, immune markers such as NK cell activity and antiphospholipid antibodies need to be evaluated.
Clinical Tip: These details are easily missed in routine examinations but have high diagnostic value for patients who have experienced one or more failed transfers.

Clinical Interpretation of Key Examination Indicators

AMH (Anti-Müllerian Hormone)

  • >2.0 ng/mL: Good ovarian reserve
  • 1.0–2.0 ng/mL: Moderate reserve
  • 0.5–1.0 ng/mL: Diminished reserve
  • <0.5 ng/mL: Severely diminished reserve

AMH primarily reflects the quantity of follicles, not quality. Low AMH does not mean poor embryo quality; it simply means fewer eggs may be available.

FSH (Follicle-Stimulating Hormone)

  • <8 IU/L: Normal
  • 8–12 IU/L: Ovarian response may be reduced
  • >12 IU/L: Significantly reduced ovarian response

FSH is measured on day 2–3 of the menstrual cycle and is a classic indicator for assessing ovarian reserve, but it is subject to significant cycle-to-cycle variability.

Antral Follicle Count

  • >12: Good ovarian reserve
  • 6–12: Moderate reserve
  • <6: Diminished reserve

Endometrial Thickness

  • 7–12 mm: Suitable for transfer
  • <7 mm: Protocol adjustment may be needed
  • >12 mm: Usually not a concern, but pathology should be ruled out

Frequently Asked Questions

Q1: My AMH is very low. Is there still hope for IVF in Thailand?
Low AMH mainly affects the number of eggs retrieved, but it does not necessarily mean poor egg quality. For patients with low AMH, doctors may use a milder ovarian stimulation protocol or consider natural cycle egg retrieval. The key is to obtain a few but high-quality eggs. Younger patients with low AMH generally have higher success rates than older patients with low AMH.
Q2: I have had several failed transfers. What is the reason?
The causes of recurrent implantation failure are complex and may involve embryonic factors (chromosomal aneuploidy), uterine factors (endometritis, decreased endometrial receptivity), immune factors, or coagulation abnormalities. It is recommended to investigate step by step rather than blindly repeating transfers. Hysteroscopy and endometrial microbiome testing are important diagnostic tools.
Q3: Is PGT necessary for IVF in Thailand?
Not necessarily. PGT is indicated for: female age ≥38 years, history of chromosomal abnormalities, recurrent implantation failure, recurrent miscarriage, etc. It is not mandatory for young patients without a genetic history. PGT can screen for chromosomally normal embryos but may also result in the loss of some transferable embryos, so the pros and cons need to be weighed.
Q4: Does the ovarian stimulation protocol affect IVF success rates in Thailand?
It has a significant impact. The stimulation protocol needs to be individualized based on the patient's ovarian reserve, age, BMI, and previous response. An inappropriate protocol choice may lead to an insufficient number of eggs or an increased risk of OHSS. Doctors select antagonist, agonist, or mild stimulation protocols based on AMH and antral follicle count.

Observations from Practitioners

From clinical experience, among the key factors affecting IVF success rates in Thailand, the link between age and embryo chromosomal euploidy is the most difficult to overcome. Many patients place their hopes on a "good hospital" or "new technology," but ultimately, the outcome is determined by their own biological conditions.

Another common misconception is over-focusing on success rate numbers. Success rates from different centers and different populations are not directly comparable. What patients should focus on is whether the doctor has provided a comprehensive evaluation and developed a reasonable plan tailored to their individual situation, rather than a vague percentage.

Most effective strategies to improve success rates:

  • Start at an appropriate age as early as possible;
  • Choose a center with a high-quality laboratory;
  • Pursue personalized treatment for your specific issues;
  • Manage psychological stress and lifestyle (maintain BMI between 18.5–24, quit smoking, limit alcohol, and keep a regular routine).

Doctor's Advice: Before starting IVF treatment in Thailand, complete a comprehensive fertility assessment to understand your baseline conditions. Do not blindly pursue the "best" center or the "most expensive" protocol; instead, choose the path that best suits your situation. Improving success rates is a systematic process that requires cooperation between the doctor and the patient. If you have already completed some tests in your home country, it is recommended to bring the reports for the Thai doctor's reference to avoid redundant testing.

— Reproductive Medicine Editor / Clinical Reference

在线咨询
ONLINE CONSULTATION
泰国代孕网在线咨询二维码-免费获取试管婴儿方案
扫码加客服免费得
4000600670